DK1720611T3 - Diagnostisk markør for cancer - Google Patents

Diagnostisk markør for cancer

Info

Publication number
DK1720611T3
DK1720611T3 DK05707434.6T DK05707434T DK1720611T3 DK 1720611 T3 DK1720611 T3 DK 1720611T3 DK 05707434 T DK05707434 T DK 05707434T DK 1720611 T3 DK1720611 T3 DK 1720611T3
Authority
DK
Denmark
Prior art keywords
cancer
activity
viii
protein
diagnostic
Prior art date
Application number
DK05707434.6T
Other languages
English (en)
Inventor
Hermann Rogatsch
Michael Cahill
Helmut Klocker
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Priority claimed from PCT/EP2005/001567 external-priority patent/WO2005078124A2/de
Application granted granted Critical
Publication of DK1720611T3 publication Critical patent/DK1720611T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
DK05707434.6T 2004-02-16 2005-02-16 Diagnostisk markør for cancer DK1720611T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004008449 2004-02-16
DE102004038076A DE102004038076A1 (de) 2004-02-16 2004-07-29 Diagnostische Marker für Krebs
PCT/EP2005/001567 WO2005078124A2 (de) 2004-02-16 2005-02-16 Diagnostische marker für krebs

Publications (1)

Publication Number Publication Date
DK1720611T3 true DK1720611T3 (da) 2010-09-06

Family

ID=34813531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05707434.6T DK1720611T3 (da) 2004-02-16 2005-02-16 Diagnostisk markør for cancer

Country Status (9)

Country Link
CN (1) CN101027099B (da)
AT (1) ATE468158T1 (da)
DE (2) DE102004038076A1 (da)
DK (1) DK1720611T3 (da)
ES (1) ES2345392T3 (da)
HR (1) HRP20100356T1 (da)
PT (1) PT1720611E (da)
RS (1) RS51391B (da)
SI (1) SI1720611T1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ588303A (en) * 2008-04-08 2012-05-25 Japan Science & Tech Agency Method for screening cattle, cattle screened, and cattle screening kit
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
WO2013037118A1 (zh) * 2011-09-16 2013-03-21 上海长海医院 前列腺癌的生物学标志物、治疗靶点及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000993D0 (en) * 2000-01-18 2000-03-08 Univ Nottingham Trent Cancer associated genes and their products
EP1272617B1 (en) * 2000-04-01 2011-04-27 Onyvax Limited Prostate cell lines and their use
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
RS51391B (en) 2011-02-28
ES2345392T3 (es) 2010-09-22
SI1720611T1 (sl) 2010-09-30
DE102004038076A1 (de) 2005-09-01
CN101027099B (zh) 2013-04-03
DE502005009597D1 (de) 2010-07-01
HRP20100356T1 (hr) 2010-09-30
PT1720611E (pt) 2010-08-26
CN101027099A (zh) 2007-08-29
ATE468158T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
RS49995B (sr) Primena dialkil fumarata
BRPI0411552A (pt) anticorpos especìficos a esclerostina e métodos para aumentar a mineralização óssea
Lange et al. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene
CO5721011A2 (es) Elementos de respuesta al estrogeno de bmp-2 y metodos de uso de los mismos
BR0312276A (pt) Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
DK2208784T3 (da) Celleproliferationsinhibitorer indeholdende anti-glypican-3-antistof
CL2008003572A1 (es) Molecula de acido nucleico que codifica para una proteina insecticida de la familia cry9; dicha proteina; casete de expresion que comprende dicha molecula de acido nucleico; y microorganismo transformado con dicha molecula; composicion plaguicida; y metodo para controlar un insecto plaga (div.sol. 3289-04).
FR2889921B1 (fr) Ensemble de conditionnement et d'application comportant un dispositif magnetique.
BRPI0519241A2 (pt) agonistas, composiÇÕes, mÉtodos e usos de glp-1
BRPI0417721A (pt) kit contendo um medicamento farmacêutico, métodos para preparar uma formulação lìquida de um polipeptìdeo de fator de coagulação sangüìnea e para tratar uma sìndrome responsiva a fator de coagulação, uso de um polipeptìdeo de fator vii, composição, e, métodos para preparar as composições e para tratar uma sìndrome responsiva a fvii
CY1113651T1 (el) Αντιφλεγμονωδη σκευασματα
BRPI0412971A (pt) método de alongamento do cabelo
BR0316923A (pt) Polipeptìdeo mitoneet de membranas mitocondriais, seus moduladores e métodos para utilização do mesmo
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
BR0214450A (pt) ácidos hidroxâmicos de sulfona aromáticos e uso dos mesmos como inibidores de protease
DK1720611T3 (da) Diagnostisk markør for cancer
BR0309127A (pt) Composição para proliferação de células
DE60330180D1 (de) Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid
BRPI0512336A (pt) métodos de diagnósticos para osteoporose
ES2152107T3 (es) Uso de polisacaridos sulfatados en el tratamiento de heridas cronicas.
Imai et al. Oral malodorous compound inhibits osteoblast proliferation
BR0209206A (pt) Clatrato de hidrato de azitromicina com 1,2-propileno glicol, processo para a sua preparação e composição farmacêutica compreendendo o mesmo
BRPI0211635B8 (pt) composto ciclo-hexil-sulfona, uso do mesmo, e, composição farmacêutica
BR0211697A (pt) Marcador de câncer e usos deste na diagnose de câncer
AR058510A1 (es) Procedimiento de diagnostico de enfermedades hepaticas y de muestreo de moleculas para el tratamiento de estas enfermedades